Antibody Therapeutics for Life

Notices


No Title Written by Written date Inquire
59   2019 KAIST CHIP Advisory Workshop   Admin   2019-06-21   1,465  
58   Company Presentation Onsite Information   Admin   2019-05-20   9,746  
57   [KSMO 2019] Invitation Letter_Dr. Jin-San Yoo   Admin   2019-03-27   12,362  
56   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a lecture at DGIST Brain and Cognitive Sciences   Admin   2019-02-07   41,963  
55   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th,   Admin   2019-02-07   11,401  
54   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to host CEO Roundtable at WuXi Healthcare Forum 2019 March 5-6,   Admin   2019-02-07   7,176  
53   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).   Admin   2019-02-07   4,554  
52   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting   Admin   2019-02-07   2,539  
51   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe   Admin   2019-02-07   13,793  
50   Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo   Admin   2019-01-14   1,950